Samsung acquires Xealth to power data-driven, connected care at scale

Samsung Electronics has completed the acquisition of Xealth, the US-based digital health platform that connects clinicians, patients and digital tools, in a move aimed at accelerating its vision for AI- and data-powered connected care.

The deal, originally announced in July, brings together Samsung’s global device ecosystem – including wearables and smartphones – with Xealth’s platform, which is embedded in electronic health records (EHRs) and used by leading US health systems to prescribe and manage digital health solutions. Financial terms were not disclosed.

Samsung says integrating Xealth will help tackle one of healthcare’s persistent challenges: fragmented data. Millions of people use consumer wearables and health apps every day, yet this information often sits outside clinical workflows and hospital systems.

By linking home health monitoring data with medical records and clinician tools, the combined offering aims to unlock earlier interventions, richer insights and more continuous care.

“Samsung’s leadership in innovative technologies combined with Xealth’s deep expertise and extensive healthcare network will deliver seamless connected care at scale,” said Dr Hon Pak, senior vice president and head of the Digital Health Team in Samsung’s Mobile eXperience Business. “Leveraging its AI-powered analytics, we can turn clinical data into insights that enable faster, more accurate diagnoses and more effective disease monitoring. We are ushering in a new era of healthcare, and it will be transformative for patients everywhere.”

Xealth, which was spun out of the Providence health system, acts as an orchestration layer for digital health. Embedded in the EHR, it enables clinicians to prescribe, automate and measure the impact of digital tools – including apps, remote monitoring services and wearable data – within existing workflows. Health systems can manage multiple solutions through a single interface, while maintaining control over how they filter, govern and use data.

The company works with more than 500 US hospitals, including Advocate Health and Banner Health, and over 70 digital health solution partners. These partners will gain access to Samsung’s platform and device ecosystem, extending the reach of their tools into a broader connected care environment.

“Our mission from day one has been to strengthen the bond between medical care teams and their patients through familiar technologies,” said Mike McSherry, CEO and co-founder of Xealth. “That driving force is supported and propelled through Samsung in a way that will bring truly connected care and add fresh context to the patient experience in a way not possible before. Together with Samsung and our network of healthcare leaders, we will design a bridge between home health monitoring and clinical decision-making, with provider workflows and the patient–provider relationship at the core.”

Samsung positions the acquisition as part of a wider medtech strategy that spans digital health, medical imaging and smart devices. The company says combining its hardware, AI capabilities and global footprint with Xealth’s software and health system relationships will enable more personalised, preventative care – from wellness tracking through to long-term disease management.

The transaction has cleared all customary closing conditions, including regulatory approvals. Xealth will continue to operate under its existing brand, with its leadership team remaining in place as it becomes a central component of Samsung’s connected care proposition.